Ulcer drugs are different race
Study found that, due to genetic differences in the treatment of gastric ulcer and other acid-related diseases, the yellow-white just taking half the dose, you can achieve the same effect.
Guangzhou No. 1 People’s Hospital of Gastroenterology, deputy chief physician Wang told reporters that human genes can be divided into three types: extensive metabolizers, intermediate metabolizers and poor metabolizers. Mostly white with a strong metabolic type, while the yellow people in order to intermediary metabolism type and mostly poor metabolizers. By acid-related diseases such as gastric ulcer patients with 10 years of follow-up, they found that patients taking proton pump inhibitors such as omeprazole and other acid-suppressing drugs, in fact, no need, as before, copy the dose of white. Such as omeprazole, had previously been taking two a day, but now find that just taking a yellow, you can achieve the same effect, the intravenous drug was previously 80 mg to 160 mg per day, and now can be reduced 40 mg to 80 mg.
Wang said the findings apply not only to Chinese, and also applies to the Japanese, Koreans and all other yellow. Gastric ulcer medication reduced by half, can make a significant reduction of drug side effects, patients and dizziness, allergies, skin rash side effects will be reduced accordingly, which means that the body load of patients, especially the burden of the liver will be substantially mitigation. In addition to those who have obvious benefits of medication, dosage reduced by half will reduce the patient’s economic burden.
It is learned that, in the past in the design of a pilot program of drug doses had never considered the ethnic and genetic differences. From this perspective, the significance of the study is self-evident.
Comments
Leave a Reply
WordPress ·